Abstract-Studies have demonstrated that increased oxidative stress contributes to the pathogenesis and the development of pulmonary artery hypertension (PAH). Extracellular superoxide dismutase (SOD3) is essential for removing extracellular superoxide anions, and it is highly expressed in lung tissue. However, it is not clear whether endogenous SOD3 can influence the development of PAH. Here we examined the effect of SOD3 knockout on hypoxia-induced PAH in mice and a loss-of-function SOD3 gene mutation (SOD3 E124D ) on monocrotaline (40 mg/kg)-induced PAH in rats. SOD3 knockout significantly exacerbated 2 weeks of hypoxia-induced right ventricular (RV) pressure and RV hypertrophy, whereas RV pressure in SOD3 knockout mice under normoxic conditions is similar to wild-type controls. In untreated control rats at age of 8 weeks, there was no significant difference between wild-type and SOD3
P ulmonary artery hypertension (PAH) is a progressive disease with a very poor prognosis. PAH is characterized by a progressive elevation of pulmonary arterial pressure, ultimately inducing right ventricular (RV) hypertrophy and heart failure. Studies have demonstrated that increased oxidative stress, such as enhanced production of superoxide anions and other reactive oxygen species, may contribute to the pathogenesis and the development of idiopathic PAH in patients and to PAH secondary to high pulmonary vascular flow in lambs. 1, 2 In addition, administration of antioxidants attenuates the development of PAH, 3, 4 suggesting that pulmonary oxidative stress regulates the development of PAH.
Superoxide dismutase (SOD) is a first line of defense against free radical attack. Three SOD isozymes have been identified, including a copper/zinc-containing SOD (SOD1), which is primarily cytosolic in location; a mitochondrial manganese SOD (SOD2); and an extracellular SOD (SOD3). SOD3 is a glycoprotein secreted into the extracellular fluid by fibroblasts that binds to sulfated polysaccharides, such as heparin and heparan sulfate, 5, 6 as well as to other matrix components. 7, 8 As a result, SOD3 binds to the surface of endothelial cells and the extracellular matrix, which has a high abundance of heparan sulfate. 9 The lung is one of the organs with a relatively high SOD3 expression. 5, 10, 11 Previous studies have demonstrated that overexpression of SOD3 attenuates hypoxia-induced PAH in mice 11 and monocrotaline (MCT)-induced PAH in rats. 12 Overexpression of SOD3 also attenuates bleomycin-induced lung injury. 13 However, because SOD3 has a minimal impact on total tissue SOD activity, 10 it is uncertain whether endogenous SOD3 can influence the development of PAH. To address this question, we examined the effect of SOD3 knockout on hypoxiainduced PAH in mice and the effect of SOD3 gene mutation (SOD3 E124D ) on MCT-induced PAH in rats. Here we report that both SOD3 E124D in rats or SOD3 knockout in mice had no effect on PAH and RV hypertrophy under control conditions but resulted in significantly greater increases of RV pressure and pulmonary vascular remodeling, as well as greater RV hypertrophy in response to MCT or chronic hypoxia. The findings indicate that the endogenous SOD3 plays an important role in protecting the lung from the development of PAH and RV hypertrophy under stress conditions.
Materials and Methods

SOD3 Knockout Mice
SOD3 knockout mice and control wild-type mice used in the present study are described previously. 6, 14, 15 This study was approved by the University of Minnesota Institutional Animal Care and Use Committee.
SOD3
E124D Rats SOD3 E124D (SS-Sod3 m1Mcwi ) rats were identified as a mutation in an ethylnitrosourea mutagenesis screen by the PhysGen Program in Genomic Applications (http://pga.mcw.edu), backcrossed to the Dahl/salt-sensitive strain (SS/JrHsdMcwi), intercrossed and maintained as a homozygous colony. N2F7-F8 generation animals were provided as a gift by Transposagen Biopharmaceuticals. Because these rats were intentionally generated in the Dahl/salt-sensitive background, provided by the Medical College of Wisconsin to Charles River Laboratory, Dahl/salt-sensitive rats (SS/JrHsdMcwiCrl) were used as controls.
Hypoxia-Induced PAH in Mice
Male SOD3 knockout mice and wild-type control mice at ages 10 to 14 weeks were exposed to hypobaric hypoxia, as described by Hampl et al. 16 Briefly, the pressure in the chamber was decreased progressively from 0.8 atmosphere (16.9% O 2 ) on day 1 to 0.5 atmosphere (10.5% O 2 ) after day 7 and was maintained at 10.5% O 2 for 2 more weeks. The chamber was opened once every week for cleaning and feeding. After exposure to 10.5% O 2 for 2 weeks, mice were removed from the hypoxia chamber for determination of RV pressure and hypertrophy. The sham mice were kept in normobaric conditions.
Induction of PAH in Rats With MCT
Male SOD3
E124D rats and wild-type control rats (Dahl/salt-sensitive) at age 5 weeks were given IP injections of MCT (40 mg/kg, Sigma, St Louis, MO) or an equivalent volume of vehicle as a control. The body weights of these rats were monitored weekly. RV and aortic pressure were then determined at 3 weeks after MCT or vehicle injection, and samples were collected for related tests.
Having noticed that MCT induced more PAH and pulmonary vascular remodeling in SOD3 E124D rats, we further determined the rescue of the effect SOD mimetic, Mn(III)TMPyP (6 mg/kg per day, Cayman Chemical, Ann Arbor, MI) on MCT-induced PAH in SOD3 E124D rats. Mn(III)TMPyP treatment started immediately after injections of MCT.
Measurements of Aortic Pressure and RV Hemodynamics
At the end of the study protocol, rats and mice were first anesthetized with 1.5% isoflurane. Rats were intubated with a 16-gauge Teflon tube attached to a mechanical ventilator (Kent Scientific-Ventilator, ventilator settings: breathing frequency: 80 breaths per minute; pressures: 9/0 cm H 2 O; inspiratory/expiratory ratio: 1:1). Mice were intubated with a 20-gauge Teflon tube attached to MiniVent type 845 mouse ventilator (Hugo Sachs Elektronik). A 1.2-F pressure catheter (Scisense Inc, London, Ontario, Canada) was introduced through the right common carotid artery into the ascending aorta for measurement of systolic and diastolic blood pressures, as described previously. 14, 15, 17, 18 For RV hemodynamics, open-chest RV catheterization was performed during anesthesia with 1.5% isoflurane. 19 Data were collected when steady state was reached.
Sample Preparation
After the final hemodynamic assessment, the rats and the mice were euthanized by exsanguination, and the heart, lung, and other major organs were harvested. Lung weight was determined, and the left lung was harvested and snap frozen in liquid nitrogen for biochemical analysis. The airways of the top right lobe were subsequently perfused with and then fixed in 10% buffered formalin for histological analysis. The wet weight of RV and of left ventricle (LV)ϩseptum were weighed, and the ratios of RV weight: LVϩseptum were calculated as an index of RV hypertrophy. 20 
Histological Staining, Semiquantification of Fibrosis, and Western Blots
For staining of smooth muscle ␣-actin, tissue sections (5 m) were deparaffinized, rehydrated, antigen recovered in Tris-EDTA buffer (pHϭ9.0) for 30 minutes at 95°C to 100°C, and washed in PBS. The sections were incubated with 3% H 2 O 2 in PBS for 20 minutes followed by 1% BSA solution for 1 hour. Sections were then incubated with a monoclonal primary antibody (1:400) against smooth muscle ␣-actin (Sigma-Aldrich) overnight at 4°C and followed with Alexa Fluor 555 labeled secondary antibody against mouse Ig-G (1:1000) (Invitrogen). 15 The slides were examined using a confocal microscope (Zeiss LSM510). Measurements of ventricular fibrosis and cardiac myocyte size were performed using the method described previously. 17, 21 For methods of semiquantification of pulmonary vascular muscularization, fibrosis, and Western blots, please see the online Data Supplement at http://hyper.ahajournals.org.
Chemical Analysis
Oxidative stress marker thiobarbituric acid reactive substances content was determined as described previously. 14 Total SOD activity and SOD2 activity of lung tissues were measured using a SOD activity kit (Cayman Chemical) according the manufacturer's instructions. For relative lung SOD3 activity assay, a total of 2 g of primary antibody for SOD3 (Lifespan Biosciences) was added into 500 L of tissue extract (2 mg/mL) and then incubated for 1 to 2 hours at 4°C. Protein A/G-Agarose of 20 L was then added to the mixture and incubated at 4°C on a rocker platform overnight. The immunoprecipitates were collected by centrifugation at 3000 rpm for 30 seconds at 4°C. After gently washing with PBS 4 times, the pellets were resuspended in 400 L of buffer for SOD activity assay with the commercial kit according to the manufacturer's instructions. Control IgG was used as a negative control.
Total Antioxidant Capacity
Total antioxidant capacity of lung tissues was determined using an antioxidant power assay kit (Oxford Biomedical Research) according to the manufacturer's instructions.
Statistical Analysis
All of the values are expressed as meanϮSE or median (ϮSE). Data of 2 groups were compared with unpaired t test. Two-way ANOVA was used to test for differences between transgenic and wild-type animals under control conditions and after MCT injection. If analysis of variance demonstrated a significant effect, post hoc pairwise comparisons were made using the Fisher least significant difference test. Statistical significance was defined as PϽ0.05.
Results
SOD3 Knockout Aggravated the Hypoxia-Induced Increase of RV Pressure and Hypertrophy
To study whether SOD3 dysfunction can affect PAH in other experimental models, we determined the effect of SOD3 knockout on hypoxia-induced PAH in mice. RV pressure and the ratio of RV:LVϩseptum weight were not different between SOD3 knockout mice and wild-type controls under control normoxic conditions. However, SOD3 knockout significantly exacerbated hypoxia-induced increases of RV pressure ( Figure 1A ) and RV hypertrophy as indicated by the ratio of RV:LVϩS weight ( Figure 1B ). In addition, hypoxia caused increases of fully muscularized arterioles in both wild-type controls and SOD3 knockout mice, whereas these increases were significantly greater in the SOD3 knockout mice than in the wild-type controls ( Figures 1C and S1 ).
SOD3 E124D Mutation Had No Significant Effect on the Animals' Growth But Exacerbated the MCT-Induced Increase of RV Pressure
SOD3
E124D rats grew and developed normally. There were no significant differences in terms of body weight gain ( Figure  2A ) and left ventricular weight between SOD3 E124D rats and wild-type controls at age of 2 months (Table S1 ). In addition, E124D mutation had no effect on growth under both control conditions and after MCT injection, respectively (A). SOD3 E124D mutation had no effect on RV pressure under control conditions but further elevated the MCT-induced increase of RV pressure, indicating more severe pulmonary artery hypertension (PAH) in SOD3 E124D rats (B and C). *PϽ0.05 vs sham control; #PϽ0.05 vs corresponding wild-type (WT) rats.
systemic blood pressure, heart rate, RV pressure, and the ratio of RV:LVϩseptum weight were not different between SOD3 E124D rats and wild-type controls at age of 2 months (Tables S1 and Table S2 and Figures 2B, 2C, 2D , S2, and S3). SOD3 E124D had no detectable impact on lung SOD3 expression ( Figure S4 ) but significantly reduced lung SOD3 activity Ϸ60% in rats (0.31Ϯ0.02 in wild-type rats versus 0.12Ϯ0.06 in SOD3 E124D rats; PϽ0.05). MCT injection caused a significant increase of RV pressure in both SOD3
E124D rats and wild-type rats (48.6Ϯ1.8 mm Hg in wild-type versus 57.5Ϯ3.1 mm Hg in SOD3 E124D rats), whereas MCT caused a significantly greater increase of RV systolic pressure in SOD3 E124D rats (Table S2 and Figure 2B and 2D), indicating exacerbated PAH in SOD3 E124D rats. MCT injection significantly attenuated the weight gain in both SOD3 E124D and wild-type rats (Figure 2A ).
SOD3 E124D Mutation Aggravated the MCT-Induced Increase of RV Hypertrophy and Fibrosis
In sham (no MCT) rats at the age of 2 months, there was no significant difference among WT and SOD3 E124D rats in LVϩseptum weight (641Ϯ19.3 mg in wild-type sham versus 640Ϯ9.4 mg in SOD3 E124D rats), RV weight (162Ϯ6.7 mg in wild-type sham versus 157Ϯ2.8 mg in SOD3 E124D rats), their ratio to body weight or tibia length, and ratio of RV weight:LVϩseptum weight (0.25Ϯ0.02 in wild-type untreated sham rats versus 0.25Ϯ0.01 in SOD3 E124D untreated sham rats; Table S1 and Figure 2C ). Consistent with the significantly greater increase of RV systolic pressure in SOD3 E124D rats after MCT, SOD3 E124D rats had significantly greater increases of RV weight (239Ϯ8.7 mg in wild-type rats versus 285Ϯ10.6 mg in SOD3 E124D rats; PϽ0.05) and the ratio of RV:LVϩseptum (0.41Ϯ0.01 in wild-type rats versus 0.50Ϯ0.09 in SOD3 E124D rats; PϽ0.05) in response to MCT (Table S1 and Figure 2C ), indicating that SOD3 E124D mutation exacerbated MCT-induced RV hypertrophy. Histological analysis indicated that MCT caused a significantly greater increase of RV fibrosis ( Figures S2 and S3A ) and cardiac myocyte cross-sectional area ( Figures S2 and Figure S3B ), indicating severe RV remodeling in SOD3 E124D rats after MCT.
SOD3 E124D Mutation Exacerbated the MCT-Induced Pulmonary Vascular Remodeling
To determine the effect of SOD3 E124D on pulmonary vascular remodeling, we determined the percentage of nonmuscularized, partially muscularized, and fully muscularized small arterioles in wild-type rats and SOD3 E124D rats under sham conditions and 3 weeks after MCT injection ( Figure 3A and 3B) . MCT caused increases of fully muscularized small arterioles both in wild-type rats and SOD3 E124D rats (55.2Ϯ2.3% in wild-type rats versus 69.9Ϯ2.6% in SOD3 E124D rats; PϽ0.05), but these increases were significantly greater in the SOD3 E124D rats than in the wild-type rats (Figure 3) . Meanwhile, MCT also caused decreases of nonmuscularized small arterioles both in wild-type rats and SOD3 E124D rats (9.4Ϯ1.12% in wild-type rats versus 5.2Ϯ1.2% in SOD3 E124D rats; PϽ0.05), but these decreases were significantly greater in the SOD3 E124D rats than in the wild-type rats (Figure 3 ). In addition, SOD3 E124D rats had significantly exacerbated MCT-induced medial wall thickness ( Figure 3C ) and medial area ( Figure S5 200 m. Together, these data indicate that SOD3 E124D significantly exacerbated MCT-induced pulmonary vascular remodeling in rats.
SOD3 E124D Mutation Exacerbated the MCT-Induced Pulmonary Oxidative Stress
MCT also caused increases of pulmonary 3Ј-nitrotyrosine and thiobarbituric acid reactive substances both in wild-type rats and SOD3 E124D rats, but these increases were significantly greater in the SOD3 E124D rats than in the wild-type rats ( Figures 4A, 4B , and S7), indicating a greater degree of pulmonary oxidative stress in SOD3 E124D rats than in wild-type rats after MCT. Expressions of lung SOD1 and SOD2 were determined ( Figure  4C and 4D). SOD3 E124D had no detectable impact on lung overall antioxidant capacity, as indicated by the power of antioxidants ( Figure 4E ). Lung total SOD activity was significantly lower in SOD3 E124D rats only under control conditions, and the difference was small ( Figure 4F ). Lung SOD2 activity was unchanged in SOD3 E124D rats ( Figure S8 ). SOD mimetic Mn(III)TMPyP rescued SOD3 E124D rats from MCT-induced PAH. To further determine the impact of lung oxidative stress on the development of PAH, we determined the effect of Mn(III)TMPyP treatment (6 mg/kg per day). Mn(III)TMPyP significantly reduced MCT-induced RV pressure ( Figure 5A ), the ratio of RV weight:LVϩseptum weight ( Figure 5B), and lung vascular remodeling in SOD3 E124D rats ( Figure 5C and 5D).
Discussion
SOD3 binds to the surface of endothelial cells and the extracellular matrix and plays a critical role in removing extracellular free radical species. SOD3 is highly expressed in the lung. However, because SOD3 has a minimal impact on total tissue SOD activity, 10 it is uncertain whether endogenous SOD3 can influence the development of PAH. In the present study, we report that SOD3 E124D had no effect on overall pulmonary oxidative stress, PAH, and RV hypertrophy under control conditions but resulted in more severe pulmonary hypertension, more remodeling of the pulmonary arteries, and more RV hypertrophy and fibrosis in the setting of MCT-induced pulmonary hypertension. In addition, SOD3 knockout aggravated hypoxia-induced PAH in mice. The findings indicate that endogenous SOD3 plays an important role in protecting the lung from the development of PAH under stress conditions.
The overexpression of extracellular SOD3 reduces both hypoxia-and MCT-induced PAH. 11, 12 Similarly, an increase in SOD3 activity decreases hypoxic pulmonary vasoconstriction in bovine pulmonary artery rings. 22 Loss of SOD3 could result in increased levels of superoxide anions and downstream radicals such as peroxynitrite, decreased H 2 O 2 in extracellular space, and reduced intercellular diffusion of endothelial NO to surrounding cell types. Decreased NO bioavailability enhances the development of PAH, whereas increased NO or increase of its downstream product cGMP by inhibition of PDE5 attenuates the development of PAH. 23 Thus, it is possible that a contributing factor to the exacerbated PAH in SOD3 E124D rats and SOD3 knockout mice is increased scavenging of NO by superoxide and a subsequent reduction in NO/cGMP bioavailability.
The role of endogenous SOD3 in pulmonary vascular physiology and pathophysiology has not been clear. In these studies we show that loss of SOD3 function does not affect the tone or structure of the pulmonary arteries under normoxic control conditions. The finding that loss of function mutation in SOD3 E124D rats and SOD3 knockout in mice results in more severe pulmonary hypertension and more RV hypertrophy after MCT or hypoxia (but not under control conditions) is conceptually consistent with previous studies showing that loss of SOD3 function exacerbated infarction or pressure overload-induced left ventricular maladaptive remodeling. 14, 24 Thus, superoxide anions and possibly related downstream radicals play a detrimental role in the pathophysiology of PAH, as well as other pathological conditions, such as ventricular remodeling. 25, 26 The overall roles of SOD and oxidative stress are of particular interest in the pulmonary vasculature, because the expression of SOD2 is found to be reduced in idiopathic PAH patients and in fawn-hooded rats that spontaneously develop PAH. 27 The decrease in SOD2 precedes the development of PAH in the fawn-hooded rats. The use of an SOD mimetic prevents pulmonary hypertension and reduces RV hypertrophy in rats exposed to chronic hypoxia 28 and in fawn-hooded rats. 4 Similar to the effects of SOD3 depletion, a reduction in SOD2 should also increase superoxide anion levels and downstream radicals, such as peroxynitrite, and decrease levels of H 2 O 2 . SOD2 and SOD3 thus appear to play a major role in protecting against the development of PAH by decreasing superoxide anions and increasing H 2 O 2 and NO bioavailability. 29 These results suggest that SOD mimetics or treatments that increase endogenous SOD2 or SOD3 may have therapeutic value in PAH.
Clinical Perspectives
PAH is a progressive disease with a very poor prognosis. PAH is characterized by a progressive elevation of pulmonary arterial pressure, ultimately inducing RV hypertrophy and heart failure. Studies have demonstrated that increased oxidative stress may contribute to the pathogenesis and the development of idiopathic PAH. SOD3 plays an important role in attenuating superoxide anion in the extracellular space. However, the effect of the endogenous SOD3 on the development of PAH has not been clear. Here we report that both SOD3 knockout in mice or SOD3 E124D mutation in rats resulted in significantly greater increases of RV pressure, RV hypertrophy, and pulmonary vascular remodeling in response to hypoxia (in mice) or MCT (in rats). The findings indicate that endogenous SOD3 plays an important role in protecting against the development of PAH and subsequent RV hypertrophy under stress conditions. These results suggest that SOD mimetics or treatments that increase endogenous SOD3 may have therapeutic value in PAH. Figure S2 . Representative whole heart, cross section of ventricles, Sirius red staining for RV fibrosis, and H&E staining or WGA staining for myocyte size of RV. Figure S8 . SOD2 activity is unaffected in rats with SOD3E124D mutation.
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